Lichen International (LICN) Cash & Equivalents (2021 - 2025)

Lichen International (LICN) has 5 years of Cash & Equivalents data on file, last reported at $26.9 million in Q4 2025.

• On a quarterly basis, Cash & Equivalents rose 0.76% year-over-year to $26.9 million in Q4 2025; TTM through Dec 2025 was $26.9 million, a 0.76% increase from a year earlier, with the FY2025 full-year figure at $26.9 million, up 0.76% from the prior year.
• Cash & Equivalents for Q4 2025 stood at $26.9 million, up from $22.6 million in the prior quarter.
• Over the last five years, Cash & Equivalents for LICN reached as high as $34.2 million in Q2 2024 and fell as low as $16.8 million in Q4 2021.
• Historically, Cash & Equivalents has averaged $24.3 million across 5 years, with a median of $24.2 million in 2022.
• Across the five-year window, Cash & Equivalents jumped 81.73% in 2024 and sank 33.97% in 2025, its largest moves.
• Year by year, Cash & Equivalents stood at $16.8 million in 2021, then surged by 34.16% to $22.6 million in 2022, then rose by 14.41% to $25.9 million in 2023, then climbed by 3.31% to $26.7 million in 2024, then climbed by 0.76% to $26.9 million in 2025.
• Per Business Quant data, the three most recent Cash & Equivalents figures were $26.9 million in Q4 2025, $22.6 million in Q2 2025, and $26.7 million in Q4 2024.